A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 3, 2008, Pages 250-254

  Ramunni, Alfonso ^a,b   De Robertis, Francesca ^a   Brescia, Paola ^a   Saliani, Maria Teresa ^a   Amoruso, Michele ^a   Prontera, Maria ^a   Dimonte, Elena ^a   Trojano, Maria ^a   Coratelli, Pasquale ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NONE   (Italy)

Author keywords

Demyelinating disease; Double filtration plasmapheresis; MRI in multiple sclerosis; Multiple sclerosis

Indexed keywords

FIBRINOGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MITOXANTRONE;

ADULT; ARTICLE; CASE REPORT; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE;

ACUTE DISEASE; ADULT; DISABILITY EVALUATION; FEMALE; FIBRINOGEN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PLASMAPHERESIS;

EID: 44349193318     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00575.x     Document Type: Article

References (11)

1. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis: principles, problems and perspectives. Brain 1997 120 : 865 916.
2. Piddlesden SJ, Lassmann H, Zimprich F et al. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 1993 143 : 55.
3. Raine CS, Cannella B, Hauser SL et al. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999 46 : 144 60.
4. Storch MK, Piddlesden S, Haltia M et al. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 1998 43 : 46571.
5. Weinshenker BG, O'Brien PC, Petterson TM et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999 46 : 878 86.
6. Bruck W, Neubert T, Weber JR. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination - possible markers for an antibody-mediated process. Mult Scler 2001 7 : 173 7.
7. Keegan M, Pineda AA, McClelland RL et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002 58 : 143 6.
8. Keegan M, Konig F, McClelland R et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005 366 : 579 82.
9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 : 1444 52.
10. Bhupendra Odhavji Khatri. Therapeutic apheresis in neurological disorders. Ther Apher 1999 3 : 161 71.
11. Berger T, Rubner T, Schautzer F et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003 349 : 139 45.